Pliant Therapeutics, Inc. (PLRX)
PLRX has a market cap or net worth of $849.33 million. The enterprise value is $337.80 million.
The last earnings date was Thursday, November 9, 2023, after market close.
|Earnings Date||Nov 9, 2023|
PLRX has 59.90 million shares outstanding. The number of shares has increased by 27.54% in one year.
|Shares Change (YoY)||+27.54%|
|Shares Change (QoQ)||+0.87%|
|Owned by Insiders (%)||5.93%|
|Owned by Institutions (%)||98.02%|
|EV / Earnings||n/a|
|EV / Sales||95.29|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 19.51, with a Debt / Equity ratio of 0.02.
|Debt / Equity||0.02|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -32.50% and return on invested capital (ROIC) is -33.88%.
|Return on Equity (ROE)||-32.50%|
|Return on Assets (ROA)||-30.10%|
|Return on Capital (ROIC)||-33.88%|
|Revenue Per Employee||$22,296|
|Profits Per Employee||-$976,648|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -27.13% in the last 52 weeks. The beta is 1.25, so PLRX's price volatility has been higher than the market average.
|52-Week Price Change||-27.13%|
|50-Day Moving Average||15.08|
|200-Day Moving Average||20.88|
|Relative Strength Index (RSI)||47.73|
|Average Volume (30 Days)||574,238|
Short Selling Information
The latest short interest is 6.34 million, so 10.58% of the outstanding shares have been sold short.
|Short Previous Month||6.48M|
|Short % of Shares Out||10.58%|
|Short % of Float||14.26%|
|Short Ratio (days to cover)||11.01|
In the last 12 months, PLRX had revenue of $3.55 million and -$155.29 million in losses. Loss per share was -$2.79.
|Loss Per Share||-$2.79|
The company has $523.61 million in cash and $12.08 million in debt, giving a net cash position of $511.53 million or $8.54 per share.
|Cash & Cash Equivalents||523.61M|
|Net Cash Per Share||$8.54|
|Equity / Book Value||503.05M|
|Book Value Per Share||8.40|
In the last 12 months, operating cash flow was -$122.50 million and capital expenditures -$1.03 million, giving a free cash flow of -$123.52 million.
|Operating Cash Flow||-122.50M|
|Free Cash Flow||-123.52M|
|FCF Per Share||-$2.07|
Gross margin is 100.00%, with operating and profit margins of -4,922.65% and -4,380.45%.
Dividends & Yields
PLRX does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for PLRX is $48.45, which is 241.68% higher than the current price. The consensus rating is "Strong Buy".
|Price Target Difference||241.68%|
|Analyst Consensus||Strong Buy|
|Revenue Growth Forecast (5Y)||41.80%|
|EPS Growth Forecast (5Y)||2.35%|
This stock does not have any record of stock splits.
|Last Split Date||n/a|
PLRX has an Altman Z-Score of 12.63 and a Piotroski F-Score of 3.